IP Library Granted Patent US 8,211,889
Granted Patent B2
US 8,211,889 · App. 13/349,194 · Granted Jul 3, 2012

Prodrugs of 2,4-pyrimidinediamine compounds and their uses

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,211,889
App. No.
13/349,194
Granted
Jul 3, 2012
Kind
B2
Abstract

The present disclosure provides prodrugs of biologically active 2,4-pyrimidinediamine compounds, compositions comprising the prodrugs, intermediates and methods for synthesizing the prodrugs and methods of using the prodrugs in a variety of applications.

Claims (9)

1. A compound of the formula

or a pharmaceutically acceptable salt thereof, wherein the compound or pharmaceutically acceptable salt thereof is in the form of a hydrate.

2. The compound of claim 1 , wherein the compound is a free acid.

3. The compound of claim 1 , wherein the compound is a pharmaceutically acceptable salt.

4. The compound of claim 3 , wherein the pharmaceutically acceptable salt is an alkali metal salt.

5. The compound of claim 4 , wherein the pharmaceutically acceptable salt is a sodium salt.

6. The compound of claim 5 , wherein the pharmaceutically acceptable salt is a disodium salt.

7. The compound of claim 3 , wherein the pharmaceutically acceptable salt is an alkaline earth metal salt.

8. The compound of claim 7 , wherein the pharmaceutically acceptable salt is a calcium salt.

Assignments (2)
SECURITY INTEREST Recorded May 8, 2026
From: RIGEL PHARMACEUTICALS, INC.
To: MIDCAP FUNDING IV TRUST
Reel/Frame 075576/0880 →
SECURITY INTEREST Recorded Aug 25, 2022
From: RIGEL PHARMACEUTICALS, INC.
To: MIDCAP FINANCIAL TRUST
Reel/Frame 061327/0712 →